(Q38349760)

2 September 2017

1 reference

title

The vulnerable phase after hospitalization for heart failure (English)

1 reference

2 September 2017

0 references

1 reference

6

Mihai Gheorghiade

1 reference

2 September 2017

5

Javed Butler

1 reference

2 September 2017

2

Gregg C Fonarow

1 reference

2 September 2017

1

Stephen J Greene

1 reference

2 September 2017

3

Muthiah Vaduganathan

1 reference

2 September 2017

4

Sadiya S Khan

1 reference

PubMed ID

25666406

2 September 2017

language of work or name

English

0 references

publication date

10 February 2015

1 reference

Nature Reviews Cardiology

2 September 2017

1 reference

2 September 2017

12

1 reference

2 September 2017

4

1 reference

2 September 2017

220-229

1 reference

Rehospitalization for heart failure: problems and perspectives

2 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Thirty-day readmissions: the clock is ticking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) progr

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Congestion in acute heart failure syndromes: an essential target of evaluation and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Effect of nesiritide in patients with acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

The disconnect between phase II and phase III trials of drugs for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Need for increased awareness and evidence-based therapies for patients hospitalized for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Transitional Care Interventions to Prevent Readmissions for Persons With Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Telemonitoring in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Hospital strategies associated with 30-day readmission rates for patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Long-term effects of dietary sodium intake on cytokines and neurohormonal activation in patients with recently compensated congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Association between performance measures and clinical outcomes for patients hospitalized with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Use of aldosterone antagonists in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Angiotensin-neprilysin inhibition versus enalapril in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Improving postdischarge outcomes in patients hospitalized for acute heart failure syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Contemporary use of digoxin in the management of cardiovascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

The use of digoxin in patients with worsening chronic heart failure: reconsidering an old drug to reduce hospital admissions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Acute hemodynamic effects of digoxin alone or in combination with other vasoactive agents in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Hemoconcentration-guided diuresis in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAt

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

B-type natriuretic peptide-guided heart failure therapy: A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Therapeutic targets in heart failure: refocusing on the myocardial interstitium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Mitochondria as a therapeutic target in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Molecular and cellular basis of viable dysfunctional myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Acute heart failure syndromes: current state and framework for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

The cost of medical management in advanced heart failure during the final two years of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Are we targeting the right metric for heart failure? Comparison of hospital 30-day readmission rates and total episode of care inpatient days

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Strategies and Opportunities for Drug Development in Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Recognizing worsening chronic heart failure as an entity and an end point in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Postdischarge Assessment After a Heart Failure Hospitalization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Rehospitalization for heart failure: predict or prevent?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Reconsidering the role for digoxin in the management of acute heart failure syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

The effect of digoxin on mortality and morbidity in patients with heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Convert

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Home monitoring heart failure care does not improve patient outcomes: looking beyond telephone-based disease management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.14

Theodore E. Woodward Award: Coming in out of the rain. Relieving congestion in heart failure

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25666406

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCARDIO.2015.14

1 reference

2 September 2017

1 reference

PubMed ID

25666406